Are There Risks Associated with Targeting Tumor Vasculature?
While targeting tumor vasculature offers therapeutic potential, it also carries risks. Anti-angiogenic therapies can lead to side effects such as hypertension, bleeding, and impaired wound healing. Moreover, the suppression of normal angiogenesis could affect tissue repair and regeneration. Research continues to refine these therapies to maximize their benefits while minimizing adverse effects.
